Harrison Street, one of the largest alternative real asset investment firms dedicated to the Education, Healthcare and Storage sectors, recently announced it has acquired Osborn Triangle from a subsidiary of the Massachusetts Institute of Technology
SIM Series ultra-high speed framing cameras from Specialised Imaging incorporate an auxiliary optical port enabling secondary instruments such as streak cameras, high speed video or time resolved spectrometers to share the same optical axis as the framing channels
New England Biolabs® (NEB®) today announced the release of its Monarch Genomic DNA Purification Kit
Dr. Chris Yu, Chief Executive Officer of international life sciences corporation, Anpac Bio-Medical Science Company (Anpac Bio), announced today that the company's United Statessubsidiary, Anpac Technology USA, successfully passed the State of California survey for Clinical Laboratory Improvement Amendments or CLIA '88 certification; and thus may now offer diagnostic services to human subjects for clinical research in its San Jose, California-based laboratory
Scientists at the Johns Hopkins Kimmel Center say they have affirmed widespread inconsistencies in the use of a common laboratory procedure called immunohistochemical staining, and say the variations are making many laboratory experiments unreliable
IDbyDNA, a metagenomics technology company setting a new standard for the identification and understanding of microorganisms and their role in human health, recently announced a commercial agreement with ZeptoMetrix, a world leading laboratory quality control (QC) and reference materials supplier
Siemens Healthineers announced today the global availability of its new Atellica CH Enzymatic Hemoglobin A1c (A1c_E) Assay to assist clinicians in diagnosing and monitoring diabetes, a growing and potentially deadly disease
Uniqsis reports on two major orders for its FlowSyn flow chemistry systems from organisations involved with the South African Pharmaceutical Industry
SpeeDx Pty. Ltd. recently announced the clearance of the PlexPCR RespiVirus test from the Australian Therapeutic Goods Administration (TGA)
GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, recently announced that its multi-cancer test has been granted Breakthrough Device designation from the U.S. Food and Drug Administration (FDA)
|
|
|
|
|
|
|
|
|